NVAX Q2 2018 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+60.0% YoY

Gross Profit

$11M100.0% margin

Operating Income

-$42M-389.8% margin

Net Income

-$44M-413.0% margin

EPS (Diluted)

$-2.37

QoQ Revenue Growth

+11.6%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$40M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$286M

Total Liabilities

$374M

Stockholders' Equity

-$88M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$7M	+60.0%
Gross Profit	$11M	$7M	+60.0%
Operating Income	-$42M	-$41M	-1.3%
Net Income	-$44M	-$44M	-0.1%